1',3'-disubstituted-4-phenyl-3,4,5,6-tetra hydro-2H, 1'H-[1, 4'] bipyridinyl-2'-ones

Details for Australian Patent Application No. 2008297878 (hide)

Owner Addex Pharma S.A. OrthoMcNeil-Janssen Pharmaceuticals, Inc.

Inventors Finn, Terry Patrick; Duvey, Guillaume Albert Jacques; Cid-Nunez, Jose Maria; MacDonald, Gregor James; Lutjens, Robert Johannes; Trabanco-Suarez, Andres Avelino

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008297878

PCT Pub. Number WO2009/033704

Priority 07116390.1 14.09.07 EP

Filing date 12 September 2008

Wipo publication date 19 March 2009

Acceptance publication date 7 July 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4545 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 493/10 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Event Publications

15 April 2010 PCT application entered the National Phase

  PCT publication WO2009/033704 Priority application(s): WO2009/033704

7 July 2011 Application Accepted

  Published as AU-B-2008297878

3 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008297884-Use of peptide YY, alone or in combination with glucagon-like peptide, for use in medicine

2008297877-1,3-disubstituted-4-phenyl-1 Hpyridin-2-ones